Episode Details
Back to Episodes
Episode 235: Danny Heng and the IMDC classification in renal cancer
Season 2
Episode 235
Published 3 years, 6 months ago
Description
Daniel Heng, MD, MPH, FRCPC, joins us to discuss IMDC classification for renal cell carcinoma and the treatment of patients with favorable risk disease. Dr. Heng is a professor of oncology at the University of Calgary in Alberta, Canada, and is the leader of the International mRCC Database Consortium (IMDC) which consists of data from over 9,200 patients with mRCC treated with targeted therapies from over 38 cancer centers worldwide.